Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108437/
http://dx.doi.org/10.1371/journal.pone.0103925
_version_ 1782327759002927104
collection PubMed
description
format Online
Article
Text
id pubmed-4108437
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41084372014-07-24 Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial PLoS One Correction Public Library of Science 2014-07-23 /pmc/articles/PMC4108437/ http://dx.doi.org/10.1371/journal.pone.0103925 Text en © 2014 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
title Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
title_full Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
title_fullStr Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
title_full_unstemmed Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
title_short Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
title_sort correction: simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in assure, a randomized, open label, non-inferiority trial
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108437/
http://dx.doi.org/10.1371/journal.pone.0103925
work_keys_str_mv AT correctionsimplificationtoabacavirlamivudineatazanavirmaintainsviralsuppressionandimprovesboneandrenalbiomarkersinassurearandomizedopenlabelnoninferioritytrial

Ejemplares similares